Search results
7 Benefits of Metformin (Including Weight Loss)
MediaFeed via AOL· 2 days agoMetformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for diabetes, you probably already...
Lurie takes charge in studying drug that glows in presence of lung cancer cells
Crain s Chicago Business· 4 days agoFood & Drug Administration for Investigational New Drug approval to study the safety and feasibility ...
GT Medical and Theragenics team up to expand access to radiotherapy seeds
Medical Device Network via Yahoo Finance· 3 days agoCesium-131 is a common isotope used with low dose rate (LDR) brachytherapy, a radiation treatment...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 4 days agoSource: Global Cancer Observatory. Analysts forecast Novartis' second-quarter earnings per share to be between $1.78 and $1.84...
Tips For Seniors Over 65 With ED
MediaFeed via AOL· 5 days agoCan an 80-year-old man get hard? The short answer is yes. But there are some reasons why it may be more difficult for older men to get aroused during...
Xyosted: Mild to serious side effects and how to manage them
Medical News Today· 3 days agoXyosted (testosterone enanthate) is a brand-name injectable drug that’s prescribed for testosterone...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
NBC 17 Raleigh· 2 days agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
WTNH-TV New Haven· 2 days agoJohnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study...
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Morningstar· 6 days agoMore than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment optionsThe first-of-its-kind Esprit™ BTK Everolimus Eluting Resorbable ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement ...